P. Souverein

First name
P.
Middle name
C.
Last name
Souverein
van de Garde, E. M., Souverein, P. C., Hak, E., Deneer, V. H., van den Bosch, J. M., & Leufkens, H. G. (2007). Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens. http://doi.org/10.1097/HJH.0b013e328010520a
View
Duijnhoven, R. G., Straus, S. M., Souverein, P. C., de Boer, A., Bosch, J. L., Hoes, A. W., & De Bruin, M. L. (2014). Long-term use of 5alpha-reductase inhibitors and the risk of male breast cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-014-0455-6
View
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., et al. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
View
Warnier, M. J., Rutten, F. H., Souverein, P. C., de Boer, A., Hoes, A. W., & De Bruin, M. L. (2015). Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3792
View
Boef, A. G., Souverein, P. C., Vandenbroucke, J. P., Vlieg, van H., de Boer, A., le Cessie, S., & Dekkers, O. M. (2016). Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3956
View
Requena, G., Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., et al. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816
View
Verhaegh, B. P., de Vries, F., Masclee, A. A., Keshavarzian, A., de Boer, A., Souverein, P. C., et al. (2016). High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther. http://doi.org/10.1111/apt.13583
View
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
View
Mahmoudpour, S. H., Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., & van der Zee, A. H. M. -. (2016). Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13090
View
Spaetgens, B., de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., et al. (2017). Risk of infections in patients with gout: a population-based cohort study. Sci Rep. http://doi.org/10.1038/s41598-017-01588-5
View